+39 02 610346.1 - info@newron.com

Latest press releases

  • 24Mar
    Newron Shareholders Authorize Allocation of Additional Shares to Support Multiple Clinical Programs


  • 4Mar
    Newron to Present at the 27th Annual ROTH Conference

  • 4Mar
    Newron Pharmaceuticals reports 2014 financial results ▪ Board approves agenda for AGM on March 24, 2015


  • 2Mar
    Xadago® (safinamide) New Drug Application (NDA) Accepted for Filing by the U.S. Food and Drug Administration (FDA)


  • 26Feb
    Parkinson’s disease (PD): EU Commission approves Xadago® (safinamide) for mid-late stage PD patients

  • 5Feb
    Newron to Present at the 17th Annual BIO CEO & Investor Conference and the Leerink Global Healthcare Conference

View All

Newron share price


  • 20May
    Bio€quity Europe

    May 19-20, 2015 - InterContinental Vienna Hotel, Vienna - Austria

  • 4May
    DVFA Frühjahrskonferenz 2015

    May 4-6, 2015 - DVFA Center, Frankfurt - Germany

  • 14Apr
    Swiss Biotech Day

    April 14, 2015 - Congress Center Basel, Hall 4, Basel -Switzerland

View Event Calendar